text
stringlengths 0
3.52k
|
|---|
8.4.1 Monitor timeliness of detection and notification of immediately reportable diseases or |
events ................................ ................................ ................................ ................................ .......... 312 |
8.4.2 Monitor the timeliness of weekly reporting ................................ ................................ ....... 312 |
8.4.3 Monitor the timeliness of monthly reporting ................................ ................................ ..... 312 |
8.5 Completeness of Reporting ................................ ................................ ................................ ....... 313 |
8.5.1 Completeness of health facilities submitting surveillance forms ................................ ....... 313 |
8.5.2 Completeness of case reporting ................................ ................................ ......................... 313 |
8.5.3 Completeness of surveillance data ................................ ................................ ..................... 313 |
8.6 Report timelin ess and completeness to other levels ................................ ................................ .. 313 |
8.6.1 Identify problems and take action ................................ ................................ ...................... 314 |
8.7 Monitor the quality of surveillance activities at community level ................................ ............ 314 |
8.8 Support supervision for improving IDSR activities ................................ ................................ .. 315 |
8.8.1 Steps for conducting supportive supervision: ................................ ................................ .... 315 |
8.9 Providing feedback for improving IDSR activities ................................ ................................ ... 318 |
8.9.1 Develop and disseminate routine epidemiological bulletins ................................ .............. 319 |
8.9.2 Develop information summary sheets ................................ ................................ ................ 319 |
8.9.3 Develop di strict newsletters ................................ ................................ ............................... 320 |
8.10 Evaluate effectiveness of the performance of IDSR strategy ................................ ................. 320 |
8.10.1 Key steps in evaluation ................................ ................................ ................................ .... 320 |
8.10.2 Conducting the evaluation ................................ ................................ ............................... 321 |
Annexes to SECTION 8 ................................ ................................ ................................ .................... 323 |
Annex 8A: Indicators for monitoring IDSR core functions at the health facility level .................. 323 |
Annex 8B: Indicators for monitoring IDSR core functions at the district level ............................. 328 |
Annex 8C: Indicators for monitoring IDSR core functions at the regional level ........................... 334 |
Annex 8C: Indicators for monitoring IDSR core functi ons at the regional level ........................... 335 |
Annex 8D: Indicators monitoring IDSR core functions at the nati onal level ................................ . 342 |
Annex 8E: Monitoring Chart for performance of IDSR indicators at health facility level ............. 348 |
Annex 8F: Monitoring chart for performance of IDSR indicators at district, regional level .......... 350 |
Annex 8G: Sample form for recording timeliness and completeness of weekly / monthly reporting |
from the health facility to the district ................................ ................................ .............................. 355 |
Annex 8H: Checklist for monitoring IDSR activities at the health facility ................................ .... 357 |
Annex 8I: Indicators for monitoring the p erformance of IDSR at Member State level .................. 359 |
Annex 8J: Sample Public He alth Bulletin ................................ ................................ ....................... 360 |
SECTION 9: ELECTRONIC INTEGRATED DISEASE SU RVEILLANCE AND RESPONSE |
(eIDSR) 362 |
9.0 Electronic IDSR ................................ ................................ ................................ ........................ 362 |
9.1 eIDSR in the context of eHealth ................................ ................................ ............................... 362 |
9.2 eIDSR in the context of HMIS ................................ ................................ ................................ .. 363 |
9.3 Rationale of eIDSR ................................ ................................ ................................ ................... 364 |
9.4 Benefits of eIDSR ................................ ................................ ................................ ..................... 365 |
9.5 Key guiding principles in establishing eIDSR ................................ ................................ .......... 366 |
9.6 eIDSR development and implementation process ................................ ................................ .... 367 |
9.6.1 Process for establishing eIDSR ................................ ................................ .......................... 367 |
9.6.2 Important considerations for a successful eIDSR ................................ .............................. 370 |
9.6.3 Pot ential available tools for eIDSR ................................ ................................ .................... 371 |
9.7 Use of eIDSR in core surveillance functions ................................ ................................ ............ 371 |
9.8 Roles and Responsibilities during eIDSR implementation at different levels .......................... 372 |
9.9 Supervision, Monitoring and Evaluation ................................ ................................ .................. 373 |
9.10 eIDSR implementation in Uganda ................................ ................................ .......................... 373 |
9.10.1 Background to eIDSR implementation in Uganda ................................ ........................... 373 |
9.10.2 Objectives of the eIDSR system in Uganda ................................ ................................ ..... 374 |
9.10.3 Key capabilities of the system ................................ ................................ ......................... 374 |
9.10.4 System Enviro nment ................................ ................................ ................................ ........ 375 |
9.10.5 Information flow and management ................................ ................................ .................. 375 |
9.10.6 Features of Uganda鈥檚 eIDSR application ................................ ................................ ......... 376 |
SECTION 10: TAILORING IDSR TO EMERGENCY OR FRAGILE HEALTH SYSTEM |
CONTEXTS 379 |
10.0 Introduction ................................ ................................ ................................ ............................. 379 |
10.1 H ealth information system in emergency contexts ................................ ................................ . 379 |
10.1.1 Key definitions in emergency contexts ................................ ................................ ............ 380 |
10.2 Early Warning and Response ................................ ................................ ................................ .. 380 |
10.2.1 Why is enhanced sur veillance needed? ................................ ................................ ............ 380 |
10.2.2 What are the objectives of tailoring IDSR to emergency context? ................................ .. 381 |
10.2.3 Critical components of IDSR in emerge ncy context ................................ ........................ 381 |
10.3 Steps in implementation of IDSR in humanitarian emergencies ................................ ............ 381 |
10.4 Stakeholders in implementation of IDSR in humanitarian emergencies ................................ 383 |
10.5 Surveillance functions during an acute humanitarian emergency ................................ ........... 384 |
10.5.1 Support funct ions for surveillance in crisis affected populations ................................ .... 384 |
10.5.2 Develop priority diseases/conditions/events list ................................ .............................. 384 |
10.5.3 Identify pr iority diseases/ conditions and events ................................ ............................. 384 |
10.5.4 Alert and epidemic thresholds ................................ ................................ .......................... 384 |
10.5.5 Alert verification ................................ ................................ ................................ .............. 385 |
10.5.6 Outbreak investigation ................................ ................................ ................................ ..... 385 |
10.5.7 Report suspected cases/conditions/events ................................ ................................ ........ 385 |
10.5.8 Laboratory support ................................ ................................ ................................ ........... 385 |
10.5.9 Analyze and interpret findings ................................ ................................ ......................... 386 |
10.5.10 Monitoring and evaluation ................................ ................................ ............................. 387 |
10.5.11 Outbreak preparedness ................................ ................................ ................................ ... 387 |
10.5.12 Outbreak response ................................ ................................ ................................ .......... 387 |
10.6 Exit strategy ................................ ................................ ................................ ............................ 388 |
SECTION 11: SUMMARY GUIDELINES FOR SPECIFIC PRIORITY DISEASES AND |
CONDITIONS 390 |
11.0 Summary guidelines for specific priority diseases and conditions ................................ ..... 390 |
Acute viral hepatitis ................................ ................................ ................................ ........................ 395 |
Annexes to SECTION 11 ................................ ................................ ................................ .................. 557 |
Annex 11A : Reporting form for adverse events following immunization (AEFI) ................... 558 |
Annex 11B : Acute flaccid paralysis - case investigation form ................................ ................. 560 |
Annex 11C : Cholera - case-based investigation form ................................ .............................. 561 |
Annex 11D: Guinea worm - case investigation form ................................ ................................ ..... 564 |
Annex 11E : Maternal death - reporting form ................................ ................................ ........... 569 |
Annex 11F: Measles case investigation form ................................ ................................ ................. 571 |
Annex 11G: Neonatal Tetanus case investigation f orm ................................ ............................. 573 |
Annex 11H New -born Perinatal Death Audit Form. ................................ ................................ . 576 |
Annex 11I: Tuberculosis - MDR and XDR TB - case-based reporting form ................................ 580 |
Annex 11J Viral haemorrhagic fever - case reporting form ................................ ..................... 581 |
Annex 11K: Viral Haemorrhagic Fever Case Investigation Form ................................ .................. 582 |
Annex 11L: Human Anthrax Case Investigation Form ................................ ................................ .. 584 |